4.3 Article

Effect of Y6, an epigallocatechingallate derivative, on reversing doxorubicin drug resistance in human hepatocellular carcinoma cells

Journal

ONCOTARGET
Volume 8, Issue 18, Pages 29760-29770

Publisher

IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.15964

Keywords

Y-6; epigallocatechin-3-gallate (EGCG); multidrug resistance; resistance reversal agent; doxorubicin

Funding

  1. Natural Science Foundation of China [81160532]
  2. Ph.D. Programs Foundation of Ministry of Education of China [20134503110007]
  3. Innovation Project of Guangxi Graduate Education
  4. Ray Biotech Co. (Atlanta, GA)

Ask authors/readers for more resources

Cancer cells can acquire resistance to a wide variety of diverse and unrelated drugs, this phenomenon is termed multidrug resistance (MDR). Multidrug resistance has been an obstacle to the success of cancer chemotherapy. The present study investigated the reversal effect of Y-6, a new compound obtained by chemically modifying the structure of epigallocatechin-3-gallate (EGCG) extracted from green tea. Y-6 was proven to be effective in inhibiting cell proliferation and reversing drug resistance in doxorubicin (DOX) resistant human hepatocellular carcinoma cells (BEL-7404/DOX). BEL-7404/DOX cells were treated with either doxorubicin combination regimen (doxorubicin plus Y-6 or epigallocatechin-3-gallate or verapamil separately) or doxorubicin alone. The results showed that cell proliferation was inhibited and late cell apoptosis increased in the combination treatment group, especially in the group treated with doxorubicin plus Y-6. Further analysis revealed that the expressions of hypoxia-inducible factor-1 alpha and multidrug resistance 1/P-glycoprotein decreased at both messenger RNA and protein levels by treatments with combined drugs compared to doxorubicin alone. Our results indicated that Y-6, as a drug resistance reversal agent, increased the sensitivity of drug resistant cells to doxorubicin. The mechanisms of actions of Y-6 in reversal effect were associated with the decreased expression of hypoxia-inducible factor-1 alpha and multidrug resistance 1/P-glycoprotein.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

The Synergistic Effect of Ruthenium Complex increment-Ru1 and Doxorubicin in a Mouse Breast Cancer Model

Xing-Guo Tang, Ke Lin, Shun-Wen Guo, Yi Rong, Dan Chen, Zhe-Sheng Chen, Feng-Feng Ping, Jin-Quan Wang

Summary: This study confirmed that the increment-Ru1/Dox combination had a synergistic effect in inhibiting tumor growth in a mouse xenograft model. It was found that this combination treatment promoted tumor cell apoptosis and reduced cardiac fibrosis and iron accumulation caused by doxorubicin. Further investigation revealed that doxorubicin regulated iron accumulation via the ferroptosis pathway and the expression of lipid peroxidation-related proteins. Therefore, the increment-Ru1/Dox combination therapy shows promise in reducing the toxic side effects of doxorubicin, especially cardiac injury.

RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2023)

Review Pharmacology & Pharmacy

Progress in the studies on the molecular mechanisms associated with multidrug resistance in cancers

Lei Zhang, Biwei Ye, Zhuo Chen, Zhe-Sheng Chen

Summary: Chemotherapy is an important method for treating cancer, but multi-drug resistance (MDR) is a major reason for its failure. Almost all anti-tumor drugs develop drug resistance over time, reducing their effectiveness in killing cancer cells. Chemoresistance can lead to rapid cancer recurrence and patient death.

ACTA PHARMACEUTICA SINICA B (2023)

Article Physics, Multidisciplinary

Dichroism in the ultrafast ARPES response and valence band orbital nature of BaNiS2

Jiuxiang Zhang, Zhesheng Chen, Jonathan Caillaux, Yannick Klein, Andrea Gauzzi, Azzedine Bendounan, Amina Taleb-Ibrahimi, Luca Perfetti, Evangelos Papalazarou, Marino Marsi

Summary: Time-resolved ARPES provides a method to investigate the band structure and dynamics of excited electronic states in solids. Understanding the orbital character of bands near the Fermi level is crucial for explaining exotic phenomena in quantum materials. By conducting polarization-dependent time-and angle-resolved photoemission spectroscopy and analyzing the photoelectron yield for different crystal orientations, we determine the orbital character of bands above and below the chemical potential in the Dirac semimetal BaNiS2. Our results demonstrate the significance of controlling and understanding matrix elements' effects in time-resolved photoemission spectroscopy for the study of quantum materials.

EUROPEAN PHYSICAL JOURNAL-SPECIAL TOPICS (2023)

Article Chemistry, Multidisciplinary

Manipulating Dirac States in BaNiS2 by Surface Charge Doping

Jiuxiang Zhang, Thibault Daniel Pierre Sohier, Michele Casula, Zhesheng Chen, Jonathan Caillaux, Evangelos Papalazarou, Luca Perfetti, Luca Petaccia, Azzedine Bendounan, Amina Taleb-Ibrahimi, David Santos-Cottin, Yannick Klein, Andrea Gauzzi, Marino Marsi

Summary: In the Dirac semimetal BaNiS2, the Dirac nodes can be moved along the Gamma-M symmetry line in reciprocal space by varying the concentration of adsorbed K atoms. This peculiar feature offers a promising tool for engineering Dirac states at surfaces, interfaces, and heterostructures, as demonstrated by first-principles calculations considering the effect of charge transfer gap.

NANO LETTERS (2023)

Article Biochemistry & Molecular Biology

Design, synthesis, and biological evaluation of phenylurea indole derivatives as ABCG2 inhibitors

Gao-Jie Ye, Chao-Yun Cai, Zhuo-Xun Wu, Qiu-Xu Teng, Jing-Quan Wang, Zhe-Sheng Chen, Bo Wang

Summary: Three series of phenylurea indole derivatives were synthesized with potent inhibitory activities on ABCG2. Four phenylurea indole derivatives with extended 7C system showed the most potent ABCG2 inhibition and no inhibition on ABCB1. Further investigation on two compounds revealed that they increased the accumulation of mitoxantrone in ABCG2-overexpressing cells and stimulated the ATP hydrolysis of ABCG2 transporter.

BIOORGANIC CHEMISTRY (2023)

Article Oncology

A multi-functional nano-system combining PI3K-110α/β inhibitor overcomes P-glycoprotein mediated MDR and improves anti-cancer efficiency

Ruikun Lin, Lei Zhang, Biwei Ye, Yanan Wang, Yi-Dong Li, Hsu Jason, Wenzhen Liu, Ping Hu, Jincan Chen, Zhe-Sheng Chen, Zhuo Chen

Summary: Our study demonstrates a novel approach to treat multidrug resistance in cancer by targeting and inhibition of P-gp using a nanoparticle system. In vitro and in vivo experiments showed that this nanoparticle system significantly enhanced the efficacy of chemotherapy, reversed drug resistance, inhibited cell proliferation, induced apoptosis, and prevented cancer cell metastasis, with no apparent toxicity.

CANCER LETTERS (2023)

Review Pharmacology & Pharmacy

Advances in receptor chromatography for drug discovery and drug-receptor interaction studies

Jia Fu, Wei Qin, Lu-Qi Cao, Zhe-Sheng Chen, Hui-Ling Cao

Summary: This review summarizes the applications and immobilization methods of receptor chromatography, which is widely used for high-throughput separation and accurate drug screening. The review focuses on screening active compounds in natural products, as well as the design and application of receptor chromatography in drug-receptor interactions.

DRUG DISCOVERY TODAY (2023)

Review Pharmacology & Pharmacy

Sunitinib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkers

Juan Jin, Yuhao Xie, Jin-Shi Zhang, Jing-Quan Wang, Shi-Jie Dai, Wen-fang He, Shou-Ye Li, Charles R. Ashby Jr, Zhe-Sheng Chen, Qiang He

Summary: Renal cell carcinoma (RCC) is the most prevalent type of kidney cancer, and targeted therapy with Sunitinib has become the main treatment option due to the lack of efficacy in radiation therapy and chemotherapy. However, many patients develop resistance to Sunitinib within months of therapy. In this review, we discuss the molecular mechanisms of Sunitinib resistance, strategies to overcome it, and potential predictive biomarkers.

DRUG RESISTANCE UPDATES (2023)

Review Pharmacology & Pharmacy

Antimicrobial peptides for combating drug-resistant bacterial infections

Jiaqi Xuan, Weiguo Feng, Jiaye Wang, Ruichen Wang, Bowen Zhang, Letao Bo, Zhe-Sheng Chen, Hui Yang, Leming Sun

Summary: The long-term use of antibiotics leading to drug resistance has become a major concern. As the problem worsens, infections caused by multiple bacteria are increasing rapidly and posing serious threats to human health. Antimicrobial peptides (AMPs) offer a promising alternative to traditional antibiotics as they exhibit strong antimicrobial activity and unique mechanisms against drug-resistant bacterial infections. Current research on AMPs focuses on integrating new technologies, such as modifying the amino acid structure and exploring different delivery methods. This article provides valuable insights into the properties, mechanisms, and advancements of AMPs in combating drug-resistant bacterial infections.

DRUG RESISTANCE UPDATES (2023)

Article Oncology

The Prognostic and Drug-targeting Value of Lymphoid Enhancer-binding Factor-1 in Hepatocellular Carcinoma

Ruixiang Guo, Huiru Dai, Fuweijian Liu, Minling Liu, Xueying Li, Tingwei Li, Jiehao Liao, Zhe-Sheng Chen, Yuchen Liu, Shuo Fang

Summary: LEF1 has been found to be significantly associated with high histological grade in hepatocellular carcinoma (HCC) and its overexpression is correlated with poor prognosis. LEF1 may regulate the cell cycle, WNT signaling pathway, and NOTCH signaling pathway in HCC. It could serve as a potential drug target for HCC.

RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2023)

Article Pharmacology & Pharmacy

I13 overrides resistance mediated by the T315I mutation in chronic myeloid leukemia by direct BCR-ABL inhibition

Congying Gao, Lei Zhang, Yun Xu, Xiangyu Ma, Peilei Chen, Zhe-Sheng Chen, Liuya Wei

Summary: In this study, the potent histone deacetylase inhibitor I13 was assessed for its effect on chronic myeloid leukemia (CML) cells harboring T315I-mutated and wild-type BCR-ABL. I13 showed strong activity against both types of cells, inducing cell differentiation and suppressing proliferation by causing cell cycle G0/G1-phase accumulation. It was found that I13 blocked the CML signaling pathway by depleting BCR-ABL, resulting in cell differentiation. These findings highlight I13 as a BCR-ABL modulator for overcoming drug resistance caused by T315I-mutated BCR-ABL and have implications for CML therapy development.

FRONTIERS IN PHARMACOLOGY (2023)

Article Chemistry, Multidisciplinary

MYH10 Combines with MYH9 to Recruit USP45 by Deubiquitinating Snail and Promotes Serous Ovarian Cancer Carcinogenesis, Progression, and Cisplatin Resistance

Longyang Liu, Chunlin Chen, Ping Liu, Jing Li, Zhanjun Pang, Jiayu Zhu, Zhongqiu Lin, Haixu Zhou, Yingying Xie, Tiancai Lan, Zhe-Sheng Chen, Zhaoyang Zeng, Weiyi Fang

Summary: In this study, the expression and function of MYH10 in serous ovarian cancer (SOC) were investigated. It was found that MYH10 is associated with the invasive capacity and cisplatin resistance of SOC cells. Further experiments revealed that MYH10 interacts with MYH9 to promote tumorigenesis, progression, and cisplatin resistance in SOC. Clinical samples also showed elevated expression of MYH10 in SOC samples, which correlated positively with MYH9 expression. Co-expression of MYH10+/MYH9+ was identified as an independent prognostic factor for SOC patient survival.

ADVANCED SCIENCE (2023)

Editorial Material Immunology

Editorial: Role of gut microbiota in diabetes mellitus and tumor immunity

Jingxian Chen, Zhesheng Chen, Barkat Ali Khan, Kaijian Hou

FRONTIERS IN IMMUNOLOGY (2023)

Review Oncology

The Battlefield of Chemotherapy in Pediatric Cancers

Letao Bo, Youyou Wang, Yidong Li, John N. D. Wurpel, Zoufang Huang, Zhe-Sheng Chen

Summary: The survival rate for pediatric cancers has significantly improved in recent years. Conventional chemotherapy is crucial, especially in low- and middle-income countries with limited access to advanced treatments. Despite the expanded FDA approval of chemotherapy drugs for children, patients still face side effects and multidrug resistance remains a major challenge. This review focuses on the severe side effects of pediatric chemotherapy, mechanisms of multidrug resistance, and potential therapeutic options offered by drug transporters in pediatric tumors.

CANCERS (2023)

Article Fisheries

Effect of dietary Bifidobacterium animalis subsp. lactis BLa80 on growth, immune response, antioxidant capacity, and intestinal microbiota of juvenile Japanese seabass (Lateolabrax japonicus)

Peng Xu, Kuopeng Cui, Liming Chen, Shaoshu Chen, Zheng Wang

Summary: This study evaluated the potential of Bifidobacterium animalis subsp. lactis BLa80 as a probiotic for Japanese seabass aquaculture. The results showed that BLa80 supplementation improved survival, accelerated growth, enhanced antioxidant capacity, reduced apoptosis, and altered the gut microbiota structure of juvenile Japanese seabass.

AQUACULTURE INTERNATIONAL (2023)

No Data Available